Form 4: Acadia Healthcare Executive John S. Hollinsworth Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


John S. Hollinsworth, EVP of Operations at Acadia Healthcare Company, Inc., reports acquisition and disposal of company stock on February 28, 2024.

Summary

  • On February 28, 2024, John S. Hollinsworth, EVP of Operations at Acadia Healthcare Company, Inc., reported transactions involving the company's common stock.
  • Hollinsworth acquired 33,718 shares upon vesting of performance vesting restricted stock units awarded on April 23, 2021.
  • He also acquired 6,336 shares earned based on 2023 performance under performance vesting restricted stock units awarded on April 11, 2022, which will be issued at the end of the three-year period.
  • Additionally, 7,496 shares were acquired based on 2023 performance under performance vesting restricted stock units awarded on May 9, 2023, also to be issued at the end of the three-year period.
  • Hollinsworth disposed of 11,495 shares at a price of $83.43.
  • Following these transactions, Hollinsworth beneficially owns 120,685 shares of Acadia Healthcare Company, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The vesting of shares is positive, indicating performance achievements, but the disposal of shares introduces a slightly negative element, though it's likely for personal financial reasons.

Positives

  • The vesting of restricted stock units indicates that performance targets were met, which could be seen as a positive signal.

Negatives

  • The disposal of 11,495 shares could be interpreted negatively, although it may be for personal financial management.

Risks

  • Executive stock transactions can sometimes be misinterpreted by the market, leading to short-term price volatility.
  • The delayed issuance of some shares could create uncertainty regarding future holdings.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often scrutinized by investors for insights into management's perspective on the company's future prospects. Monitoring these transactions is a standard practice in the investment community.

Comparison to Industry Standards

  • Executive compensation packages often include restricted stock units that vest based on performance metrics, aligning management's interests with those of shareholders.
  • The vesting and subsequent disposal of shares are typical components of these compensation plans.
  • Comparing Hollinsworth's transactions to those of executives at similar healthcare companies (e.g., Universal Health Services, HCA Healthcare) would provide context on the scale and frequency of such activities.

Stakeholder Impact

  • Shareholders may be interested in executive stock transactions as an indicator of management's confidence in the company.
  • Employees may view the vesting of performance-based equity as a sign of company success.

Key Dates

DateDescription
April 23, 2021Date of award for performance vesting restricted stock units, shares vested on 02/28/2024
April 11, 2022Date of award for performance vesting restricted stock units, shares earned based on 2023 performance, to be issued at the end of the three-year period.
May 9, 2023Date of award for performance vesting restricted stock units, shares earned based on 2023 performance, to be issued at the end of the three-year period.
February 28, 2024Date of stock transactions (acquisition and disposal).
March 01, 2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.